Cargando…

Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals

Detalles Bibliográficos
Autores principales: Thenoz, Morgan, Vernin, Céline, Pinatel, Christiane, Nazaret, Nicolas, Lachuer, Joel, Gessain, Antoine, Auboeuf, Didier, Wattel, Eric, Mortreux, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044731/
http://dx.doi.org/10.1186/1742-4690-11-S1-O66
_version_ 1782319196633300992
author Thenoz, Morgan
Vernin, Céline
Pinatel, Christiane
Nazaret, Nicolas
Lachuer, Joel
Gessain, Antoine
Auboeuf, Didier
Wattel, Eric
Mortreux, Franck
author_facet Thenoz, Morgan
Vernin, Céline
Pinatel, Christiane
Nazaret, Nicolas
Lachuer, Joel
Gessain, Antoine
Auboeuf, Didier
Wattel, Eric
Mortreux, Franck
author_sort Thenoz, Morgan
collection PubMed
description
format Online
Article
Text
id pubmed-4044731
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40447312014-06-19 Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals Thenoz, Morgan Vernin, Céline Pinatel, Christiane Nazaret, Nicolas Lachuer, Joel Gessain, Antoine Auboeuf, Didier Wattel, Eric Mortreux, Franck Retrovirology Oral Presentation BioMed Central 2014-01-07 /pmc/articles/PMC4044731/ http://dx.doi.org/10.1186/1742-4690-11-S1-O66 Text en Copyright © 2014 Thenoz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Thenoz, Morgan
Vernin, Céline
Pinatel, Christiane
Nazaret, Nicolas
Lachuer, Joel
Gessain, Antoine
Auboeuf, Didier
Wattel, Eric
Mortreux, Franck
Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals
title Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals
title_full Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals
title_fullStr Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals
title_full_unstemmed Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals
title_short Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals
title_sort alternative splicing signatures discriminate atl cells from untransformed cd4+ counterparts deriving from htlv-1 infected individuals
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044731/
http://dx.doi.org/10.1186/1742-4690-11-S1-O66
work_keys_str_mv AT thenozmorgan alternativesplicingsignaturesdiscriminateatlcellsfromuntransformedcd4counterpartsderivingfromhtlv1infectedindividuals
AT verninceline alternativesplicingsignaturesdiscriminateatlcellsfromuntransformedcd4counterpartsderivingfromhtlv1infectedindividuals
AT pinatelchristiane alternativesplicingsignaturesdiscriminateatlcellsfromuntransformedcd4counterpartsderivingfromhtlv1infectedindividuals
AT nazaretnicolas alternativesplicingsignaturesdiscriminateatlcellsfromuntransformedcd4counterpartsderivingfromhtlv1infectedindividuals
AT lachuerjoel alternativesplicingsignaturesdiscriminateatlcellsfromuntransformedcd4counterpartsderivingfromhtlv1infectedindividuals
AT gessainantoine alternativesplicingsignaturesdiscriminateatlcellsfromuntransformedcd4counterpartsderivingfromhtlv1infectedindividuals
AT auboeufdidier alternativesplicingsignaturesdiscriminateatlcellsfromuntransformedcd4counterpartsderivingfromhtlv1infectedindividuals
AT watteleric alternativesplicingsignaturesdiscriminateatlcellsfromuntransformedcd4counterpartsderivingfromhtlv1infectedindividuals
AT mortreuxfranck alternativesplicingsignaturesdiscriminateatlcellsfromuntransformedcd4counterpartsderivingfromhtlv1infectedindividuals